Inhibrx, Inc.
Biotechnology company · La Jolla, California, United States
Inhibrx, Inc. is a biotechnology company headquartered in La Jolla, California, United States. Its earliest recorded incorporation is in 2017. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $1.4 million in total, most recently in 2017. It has reported private securities offerings to the US SEC, most recently $200 million sold in a notice filed in 2023.
Inhibrx at a glance
What does Inhibrx do?
US government research funding
3 SBIR/STTR small-business research awards from US health agencies, $1.4 million in total (2017). NIH funding came from the National Institute of Allergy and Infectious Diseases.
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $200 million sold (2023).
Frequently asked questions about Inhibrx
Where is Inhibrx headquartered?
Inhibrx, Inc. is headquartered in La Jolla, California, United States.
What does Inhibrx do?
Inhibrx, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was Inhibrx founded?
The earliest incorporation on record for Inhibrx, Inc. is in 2017, according to public company registers.
Similar companies
- Alume Biosciences IncLa Jolla, California, United States
- Zura Bio LtdLa Jolla, California, United States
- Turnstone Biologics Corp.La Jolla, California, United States
- Intrinsic LifesciencesLa Jolla, California, United States
- Gri Bio Operations, Inc.La Jolla, California, United States
- Arialys Therapeutics, Inc.La Jolla, California, United States
- AeroRx Therapeutics, Inc.La Jolla, California, United States
- Talapo Therapeutics, Inc.La Jolla, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences